Patents by Inventor Colin MacKinnon

Colin MacKinnon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors
    Patent number: 10385069
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof. The compound is useful for use in the treatment of cancer, an inflammatory disorder, an autoimmunity disorder or a neurodegenerative disorder.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: August 20, 2019
    Assignee: Active Biotech AB
    Inventors: Ulf Wellmar, Stephen East, Marie Bainbridge, Colin MacKinnon, James Carr, Jonathan Hargrave
  • N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors
    Patent number: 10125125
    Abstract: A compound of formula (I), or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between SI 00A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: November 13, 2018
    Assignee: Active Biotech AB
    Inventors: Ingela Fritzson, David Liberg, Stephen East, Colin Mackinnon, Natacha Prevost
  • IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS
    Publication number: 20180282348
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof. The compound is useful for use in the treatment of cancer, an inflammatory disorder, an autoimmunity disorder or a neurodegenerative disorder.
    Type: Application
    Filed: December 4, 2015
    Publication date: October 4, 2018
    Inventors: Ulf WELLMAR, Stephen EAST, Marie BAINBRIDGE, Colin MACKINNON, James CARR, Jonathan HARGRAVE
  • N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS
    Publication number: 20180155330
    Abstract: A compound of formula (I), or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between SI 00A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.
    Type: Application
    Filed: December 8, 2017
    Publication date: June 7, 2018
    Inventors: Ingela FRITZSON, David LIBERG, Stephen EAST, Colin MACKINNON, Natacha PREVOST
  • N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors
    Patent number: 9873687
    Abstract: A compound of formula (I), or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between S100A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.
    Type: Grant
    Filed: May 14, 2014
    Date of Patent: January 23, 2018
    Assignee: Active Biotech AB
    Inventors: Ingela Fritzson, David Liberg, Stephen East, Colin Mackinnon, Natacha Prevost
  • N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS
    Publication number: 20160115158
    Abstract: A compound of formula (I), or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between S100A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.
    Type: Application
    Filed: May 14, 2014
    Publication date: April 28, 2016
    Inventors: Ingela FRITZSON, David LIBERG, Stephen EAST, Colin MACKINNON, Natacha PREVOST
  • Electronic device protection systems and methods
    Publication number: 20050243712
    Abstract: Protection systems and methods for electronic devices including at least one communication line interface are disclosed. A switch connected to each interface and a working communication path in an electronic device is adapted for connection to a protection communication path and controllable to connect each interface to either the working communication path or the protection communication path. Inter-device messaging provides for switch control by a protection device connected to the protection communication path, monitoring of devices in a protection group, protection communication path monitoring, and automatic configuration of a protection group.
    Type: Application
    Filed: April 29, 2005
    Publication date: November 3, 2005
    Inventors: Colin MacKinnon, Nigel Montgomery, Randy Law, Patrick Boily